Molecules 2020, 25, 1704
11 of 14
0
0
1
6
3
1
1
5.6, H-7 ), 7.37 (1H, d, J 8.1, H-7), 7.20 (1H, s, H-1), 7.08 (2H, m, H-2 + H-5), 7.03 (1H, t, J 8.1, H-6),
0
0
0
.92 (1H, dd, J 8.2, J 2.0, H-6 ), 6.82 (1H, d, J 8.2, H-5 ), 6.56 (1H, d, J 15.6, H-8 ), 4.93 (1H, m, H-10),
.65 (3H, s, COOCH ), 3.30 (2H, ddd, J 21.8, J 14.7, J 6.4, H-9); C NMR (100 MHz, Acetone-d6)
72.4 (C-11), 165.9 (C-9 ), 147.3 (C-7 ), 145.4 (C-3 ), 140.7 (C-4 ), 136.7 (C-8), 127.6 (C-3), 127.6 (C-1 ),
23.5 (C-1), 121.3 (C-4), 121.3 (C-6 ), 120.9 (C-5), 118.8 (C-6), 118.8 (C-8 ), 115.4 (C-5 ), 114.0 (C-2 ), 111.3
1
2
13
δ
3
1
2
3
0 0 0 0 0
0
0
0
0
(
C-7), 109.9 (C-2), 53.4 (C-10), 51.42 (COOCH ), 27.6 (C-9).
3
3
.5. General Procedure for the Preparation of the Hydroxycinnamoyl Amides 1b–5b
The 1.11 mmol of the cinnamoylamide ester were dissolved in 68 mL of a THF/H O 1:1 v/v
2
solution and cooled in an ice bath. Subsequently, 5.53 mmol of LiOH H O were added and the mixture
·
2
was stirred at room temperature. TLC analyses were performed to check the end of the reaction.
The mixture was diluted with 50 mL of distilled water and acidified with HCl 3 M till pH 2. After
extraction with ethyl acetate, the organic phase was dried over anhydrous Na SO . Evaporation of the
2
4
solvent under vacuum gave the crude product which was first purified by column chromatography on
silica gel using a 99:1 mixture of ethyl acetate: acetic acid as the eluent or by recrystallization from
petroleum ether.
0
-)-N-[4 -Hydroxy-(E)-cinnamoyl]-L-tyrosine 1b: Yield 85%. H NMR (400 MHz, Acetone-d ) δ
6
1
(
0 0 0
.80 (1H, bs, OH), 8.20 (1H, bs, OH), 7.50 (1H, d, J 15.7, H-7 ), 7.43 (2H, d, J 8.6, H-2 , H-6 ), 7.31 (1H, d,
8
0
0
NH), 7.10 (2H, d, J 8.5, H-2, H-6), 6.85 (2H, d, J 8.6, H-3 , H-5 ), 6.75 (2H, d, J 8.5, H-3, H-5), 6.45 (1H,
0
d, J 15.7, H-8 ), 4.81 (1H, dt, J = 7.8, 5.3, H-8), 3.17 (1H, dd, J 14.0, 5.3, H-7), 3.00 (1H, dd, J 14.0, 7.8,
H-7); 13C NMR (100 MHz, Acetone-d )
0 0 0
δ 172.3 (C-9), 165.9 (C-9 ), 158.9 (C-4 ), 156.1 (C-4), 140.4 (C-7 ),
6
0
0
0
0
0
0
1
30.3 (C-2, C-6), 129.5 (C-2 , C-6 ), 127.8 (C-1), 126.7 (C-1 ), 117.9 (C-8 ), 115.6 (C-3 , C-5 ), 115.1 (C-3,
20
20
D
C-5), 53.8 (C-8), 36.5 (C-7); [α]D
−
39.9 (c 0.1 MeOH) (lit. [α]
= +13.05; LC-MS (ESI ), m/z 328 ([M + H] ), (ESI ), m/z 326 ([M-H] ).
-)-N-[3 ,4 -Dihydroxy-(E)-cinnamoyl]-L-phenylalanine 2b: Yield 94%. H NMR (400 MHz,
−
26.9) [
7
]; CD (CH OH) ∆ε309nm
=
−
−
2.94,
3
+
+
−
∆
ε
= +2.17, ∆ε
2
58nm
234 nm
0
0
1
(
0
Acetone-d6)
δ
8.30 (OH), 7.44 (1H, d, NH), 7.42 (1H, d, J 15.6 Hz, H-7 ), 7.35–7.19 (5H, m), 7.08 (1H, d, J
.0 Hz, H-2 ), 6.95 (1H, dd, J 8.2, 2.0 Hz, H-6 ), 6.84 (1H, d, J 8.2 Hz, H-5 ), 6.56 (1H, d, J 15.6 Hz, H-8 ),
0
0
0
0
2
4
13
.88 (1H, dt, J 8.0, 5.4 Hz, H-8), 3.27 (1H, dd, J 13.9, 5.4 Hz, H-7), 3.09 (1H, dd, J 13.9, 8.0 Hz, H-7);
C
0 0
δ 172.2 (C-9), 165.7 (C-9 ), 147.0 (, 145.2, 140.6 (H-7 ), 137.4 (Ph), 129.3
NMR (100 MHz, Acetone-d6)
0 0 0 0
Ph), 128.3 (Ph), 127.4 (Ph), 126.6 (Ph), 120.9 (C-6 ), 118.0 (C-8 ), 115.4 (C-5 ), 114.0 (C-2 ), 53.5 (C-8), 37.3
(
(
C-7); [α]2
0
−
48.8 (c 0.1, MeOH); CD (MeOH) ∆ε
=
−
1.1, ∆ε
= 1.0, ∆ε250nm = +1.8, ∆ε230nm
−
D
330nm
−
297nm
−
+
+
=
+3.9; LC-MS (ESI ), m/z 328 ([M + H] ), (ESI ), m/z 326 ([M-H] ).
0
0
1
(
-)-N-[3 ,4 -Dihydroxy-(E)-cinnamoyl]-L-tyrosine 3b: yield 84%. H NMR (400 MHz, Acetone-d )
6
0
0
δ
7.36 (1H, d, J 15.6, H-7 ), 7.26 (1H, NH), 7.05 (2H, d, J 8.6, H-2 + H-6), 7.03 (1H, d, J 2.0, H-2 ), 6.90
0 0
1H, dd, J 8.2, J 2.0, H-6 ), 6.78 (1H, d, J 8.2 Hz, H-5 ), 6.70 (2H, d, J 8.6, H-3 + H-5), 6.51 (1H, d, J 15.6,
1 2
(
0
H-8 ), 4.75 (1H, dt, J 7.8, J 5.3, H-8), 3.10 (1H, dd, J 14.0, J 5.3, H-7), 2.95 (1H, dd, J 14.0, J 7.8, H-7);
1
2
1
2
1
2
13
0 0 0
C NMR (100 MHz, Acetone-d )
C-7 ), 131.1 (C-2 + C-6), 128.7 (C-1), 128.3 (C-1 ), 121.7 (C-6 ), 119.0 (C-8 ), 116.3 (C-5 ), 115.9 (C-3 +
C-5), 114.9 (C-2 ), 54.7 (C-8), 37.7 (C-7); [α]
δ 173.2 (C-9), 166.6 (C-9 ), 157.0 (C-4), 147.9 (C-4 ), 146.1 (C-3 ), 141.4
6
0
0
0
0
0
(
0
25
20
D
−
41.7 (c 0.1, MeOH) (lit. [α]
−
35.6) [11]; CD (MeOH):
D
+
+
−
∆
3
ε
=
31
−
1.5, ∆ε269 = +0.4, ∆ε235 = +6.5, ∆ε221
=
−
0.2; LC-MS (ESI ), m/z 344.1 ([M + H] ), (ESI ), m/z
3
−
42.0 ([M-H] ).
0
1
(
-)-N-[4 -Hydroxy-(E)-cinnamoyl]-L-tryptophan 4b: yield 91%. H NMR (400 MHz, Acetone-d )
0.05 (1H, s, OH), 8.90 (1H, bs, COOH), 7.61 (1H, d, J 7.9, H-4), 7.51 (2H, m, H-7 +NH), 7.37 (2H, d, J
.6, H-6 + H-2 ), 7.33 (1H, d, J 8.1, H-7), 7.20 (1H, s, H-1), 7.04 (1H, t, J 7.9, H-6), 6.96 (1H, t, J 7.9, H-5),
.82 (2H, d, J 8.6, H-5 + H-3 ), 6.60 (1H, d, J 15.7, H-8 ), 4.99 (1H, m, H-10), 3.42 (1H, dd, J 22.2, J
δ
6
0
1
8
6
1
(
0
0
0
0
0
1
2
1
3
4.8, H-9), 3.28 (1H, dd, J 22.2, J 6.3, H-9); C NMR (100 MHz, Acetone-d )
δ
172.9 (COOH), 166.4
1
2
6
0 0 0 0 0 0
C-9 ), 159.2 (C-4 ), 140.6 (C-7 ), 136.7 (C-8), 129.6 (C-2 + C-6 ), 127.9 (C-1 ), 126.7 (C-3), 123.6 (C-1),
0
0
0
1
2
21.4 (C-6), 118.8 (C-5), 118.5 (C-4), 117.9 (C-8 ), 115.8 (C-3 + C-5 ), 111.4 (C-7), 110.1 (C-2), 53.4 (C-10),
7.6 (C-9); [α]2
5
−
27.8 (c 0.1, MeOH); CD (MeOH): ∆ε323
1.2, ∆ε231 = +11.7, ∆ε = −3.5; LC-MS (ESI ), m/z 351.0 ([M + H] ), (ESI ), m/z 349.1 ([M-H] ).
=
−
1.4, ∆ε
=
−
0.1, ∆ε270
=
−
0.5, ∆ε
=
250
D
292
+
+
−
−
+
217